Literature DB >> 14636033

Vascular evaluation and arterial reconstruction of the diabetic foot.

Bauer E Sumpio1, Taeseung Lee, Peter A Blume.   

Abstract

Findings of diminished or absent pulses, pallor on elevation, redness of the foot on lowering of the leg, sluggish refilling of the toe capillaries, and thickened nails or absence of toe hair are consistent with impaired arterial perfusion to the foot. When ischemia is recognized as contributing to pedal ulceration and infection in the diabetic foot, quantitation of its severity may be difficult. Standard clinical evaluation of trophic changes is limited in an infected foot with its accompanying swelling, edema, and erythema. A palpable pedal pulse does not preclude the possibility of the presence of limb-threatening ischemia. Additional non-invasive vascular studies should be undertaken for these patients. Management of the diabetic foot is often a complex clinical problem. However, the principles of care are simple, including correction of systemic factors, such as blood glucose control, cardiovascular risk factor management, and smoking, as well as local factor correction, such as debridement, pressure relief, infection control, and revascularization when indicated. When a patient presents with evidence of infection, adequate drainage and antibiotic therapy are mandatory. The next step should be performed to differentiate the more common neuropathic ulcerations from the truly ischemic ulceration. Symptoms of rest pain or claudication are not often helpful because many of these patients are asymptomatic as a result of the presence of their neuropathy and inactivity. If an infected foot requires debridement or open partial forefoot amputation, observing the wound on a daily base is also important. Once infection is eradicated, there should be prompt signs of healing, including the development of wound granulation within several days. If wounds are not showing signs of prompt healing, arteriography is necessary. Early aggressive drainage, debridement, and local foot amputations combined with liberal use of revascularization results in cumulative limb salvage of 74% at 5 years in high-risk groups. Others report that pedal bypass to the ischemic infected foot is effective and safe as long as infection adequately controlled. These studies strongly suggest that early recognition and aggressive surgical drainage of pedal sepsis followed by surgical revascularization is critical to achieving maximal limb salvage in the high-risk population. Patients who have diabetes present a unique challenge in lower extremity revascularization because of the distal origination of many bypasses, distal distribution of the occlusive disease, and the frequently calcified arterial wall. An aggressive multidisciplinary approach to foot disease associated with diabetes involving the primary care provider, medical specialists, interventional radiology, and podiatric, plastic, and vascular surgeons will provide optimal medical and surgical care. Peripheral vascular disease is highly treatable if intervention is instituted in a timely and collegial fashion.

Entities:  

Mesh:

Year:  2003        PMID: 14636033     DOI: 10.1016/S0891-8422(03)00088-0

Source DB:  PubMed          Journal:  Clin Podiatr Med Surg        ISSN: 0891-8422            Impact factor:   1.231


  16 in total

Review 1.  Surgical revascularization techniques for diabetic foot.

Authors:  Siva Krishna Kota; Sunil Kumar Kota; Lalit Kumar Meher; Satyajit Sahoo; Sudeep Mohapatra; Kirtikumar Dharmsibhai Modi
Journal:  J Cardiovasc Dis Res       Date:  2013-06-18

2.  The diabetic foot: a global threat and a huge challenge for Greece.

Authors:  N Papanas; E Maltezos
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

3.  The use of an occlusion perfusion catheter to deliver paclitaxel to the arterial wall.

Authors:  Marzieh K Atigh; Emily Turner; Uwe Christians; Saami K Yazdani
Journal:  Cardiovasc Ther       Date:  2017-08       Impact factor: 3.023

Review 4.  Literature review on the management of diabetic foot ulcer.

Authors:  Leila Yazdanpanah; Morteza Nasiri; Sara Adarvishi
Journal:  World J Diabetes       Date:  2015-02-15

Review 5.  Lower limb complications of diabetes mellitus: a comprehensive review with clinicopathological insights from a dedicated high-risk diabetic foot multidisciplinary team.

Authors:  P Naidoo; V J Liu; M Mautone; S Bergin
Journal:  Br J Radiol       Date:  2015-06-25       Impact factor: 3.039

Review 6.  Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing.

Authors:  Zhao-Jun Liu; Omaida C Velazquez
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

Review 7.  [Plastic surgical reconstruction methods in interdisciplinary treatment of chronic wounds].

Authors:  T Kremer; G Germann; K Riedel; G A Giessler
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

8.  Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities.

Authors:  Sung-Whan Kim; Hong-Zhe Zhang; Longzhe Guo; Jong-Min Kim; Moo Hyun Kim
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

Review 9.  Contemporary evaluation and management of the diabetic foot.

Authors:  Bauer E Sumpio
Journal:  Scientifica (Cairo)       Date:  2012-10-09

Review 10.  Becaplermin gel in the treatment of diabetic neuropathic foot ulcers.

Authors:  Nikolaos Papanas; Efstratios Maltezos
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.